N-acyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

Term ID

CHEBI:70814

Synonyms

N-acyl-1-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

Definition

A glucosylceramide in which the sphingoid base is 4-hydroxy-15-methylhexadecasphinganine and the D-glucosyl residue has beta-configuration at the anomeric centre.

References

PMID:7651085

Ontology

ChEBI ( EBI )

Relationships

is a type of: 15-methylhexadecaphytosphingosine beta-D-glucosylceramide

15-methylhexadecaphytosphingosine beta-D-glucosylceramide Show first 5 Terms
has subtype: N-(2-hydroxydocosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyhenicosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyheptacosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyheptadecanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyhexacosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine ... Show All 30 Terms

N-(2-hydroxydocosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyhenicosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyheptacosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyheptadecanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyhexacosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyhexacosatetraenoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyhexadecanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyicosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxynonadecanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyoctacosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxyoctadecanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxypentacosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxytetracosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-(2-hydroxytricosanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-docosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-henicosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-heptacosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-heptadecanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-hexacosadienoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-hexacosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-hexacosatetraenoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-hexacosatrienoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-hexadecanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-icosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-nonadecanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-octacosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-octadecanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-pentacosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-tetracosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine N-tricosanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine Show first 5 Terms

Phenotype

Phenotype resulting from N-acyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

Phenotype where environments contain N-acyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

Phenotype modified by environments containing N-acyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

Human Disease Model